TLR-9 signaling and TCR stimulation co-regulate CD8+ T cell-associated PD-1 expression

Immunology Letters

Volumn 127, Issue 1, 2009, Pages 60-67

  Wong, Raymond M ^a   Smith, Kent A ^a   Tam, Victor L ^a   Pagarigan, Robb R ^a   Meisenburg, Brenna L ^a   Quach, Angeline M ^a   Carrillo, Mayra A ^a   Qiu, Zhiyong ^a   Bot, Adrian I ^a  

^a MannKind Corporation   (United States)

Author keywords

Adjuvant; Antigen; Costimulation; T cells; Vaccination

Indexed keywords

ADJUVANT; CPG OLIGODEOXYNUCLEOTIDE; EPITOPE; MELAN A; PEPTIDE VACCINE; PROGRAMMED DEATH 1; RECEPTOR; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HOMEOSTASIS; IMMUNITY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VACCINATION;

ANIMALS; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; DNA; FEMALE; GENE EXPRESSION REGULATION; HLA-A ANTIGENS; IMMUNIZATION; LIGANDS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 70350702656     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.09.002     Document Type: Article

References (25)

1. Sharpe A.H., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8 (2007) 239-245
2. Hokey D.A., Johnson F.B., Smith J., Weber J.L., Yan J., Hirao L., et al. Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. Eur J Immunol 38 (2008) 1435-1445
3. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
4. + T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110 (2007) 928-936
5. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (2006) 350-354
6. + T cell survival in HIV infection. J Exp Med 203 (2006) 2281-2292
7. + T cells leads to reversible immune dysfunction. Nat Med 12 (2006) 1198-1202
8. + T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 109 (2007) 4671-4678
9. Penna A., Pilli M., Zerbini A., Orlandini A., Mezzadri S., Sacchelli L., et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45 (2007) 588-601
10. Radziewicz H., Ibegbu C.C., Fernandez M.L., Workowski K.A., Obideen K., Wehbi M., et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81 (2007) 2545-2553
11. Urbani S., Amadei B., Tola D., Massari M., Schivazappa S., Missale G., et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 80 (2006) 11398-11403
12. Boni C., Fisicaro P., Valdatta C., Amadei B., Di Vincenzo P., Giuberti T., et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81 (2007) 4215-4225
13. Thompson R.H., Dong H., Lohse C.M., Leibovich B.C., Blute M.L., et al. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res 13 (2007) 1757-1761
14. Wong R.M., Scotland R.R., Lau R.L., Wang C., Korman A.J., Kast W.M., et al. Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. Int Immunol 19 (2007) 1223-1234
15. Berger R., Rotem-Yehudarm R., Slama G., Landes S., Kneller A., Leiba M., et al. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res 14 (2008) 3044-3051
16. Ha S.J., Mueller S.N., Wherry E.J., Barber D.L., Aubert R.D., Sharpe A.H., et al. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 205 (2008) 543-555
17. + T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 185 (1997) 2043-2051
18. Ballas Z.K., Krieg A.M., Warren T., Rasmussen W., Davis H.L., Waldschmidt M., et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 167 (2001) 4878-4886
19. Johansen P., Häffner A.C., Koch F., Zepter K., Erdmann I., Maloy K., et al. Direct intralymphatic injection of peptide vaccines enhances immunogenicity. Eur J Immunol 35 (2005) 568-574
20. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 198 (2003) 63-69
21. Smith K.A., Tam V.L., Wong R.M., Pagarigan R.R., Meisenburg B.L., Joea D.K., et al. Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 27 (2009) 2603-2615
22. Kinter A.L., Godbout E.J., McNally J.P., Sereti I., Roby G.A., O'Shea M.A., et al. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 181 (2008) 6738-6746
23. Rahman A.H., Taylor D.K., and Turka L.A. The contribution of direct TLR signaling to T cell responses. Immunol Res 45 (2009) 25-36
24. Zhong X., Bai C., Gao W., Strom T.B., and Rothstein T.L. Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger. Int Immunol 16 (2004) 1181-1188
25. Kaisho T., and Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589 (2002) 1-13